Nina S Kjellson sold $194k of TYRA
director at Tyra Biosciences, Inc.. 11,569 shares at an average of $16.79, traded Nov 4, 2024, filed Nov 6, 2024.
Score components
- +15RoleDirector
- +12Trade size$194k at market
- 0Share of holdings soldSold 0.3% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -8.1%, 3m -20.2%, 6m -46.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-122639, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 4, 2024 | SOpen-market sale Common Stockindirect: By Canaan XI L.P. | -960 | $17.01 | $16k | 3,811,814 | Nov 6, 2024 |
| Nov 4, 2024 | SOpen-market sale Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7 | -116 | $17.01 | $1,973 | 458,390 | Nov 6, 2024 |
| Nov 5, 2024 | SOpen-market sale Common Stockindirect: By Canaan XI L.P. | -9,367 | $16.77 | $157k | 3,802,447 | Nov 6, 2024 |
| Nov 5, 2024 | SOpen-market sale Common Stockindirect: By 2020+ Co-Investment L.P. - Series 7 | -1,126 | $16.77 | $19k | 457,264 | Nov 6, 2024 |
Related signals
Other insiders at Tyra Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | TYRAbuy Tyra Biosciences, Inc. | Rehan Verjee director | $20k 972 shares | - | |
| 8Weak | Tyra Biosciences, Inc. | Daniel Bensen Chief Discovery Officer | $263k 8,000 shares | -5% | |
| 8Weak | Tyra Biosciences, Inc. | Daniel Bensen Chief Discovery Officer | $228k 8,000 shares | -5% | |
| 16Weak | Tyra Biosciences, Inc. | Robert J More director | $250k 10,000 shares | -0% | |
| 15Weak | Tyra Biosciences, Inc. | Daniel Bensen Chief Discovery Officer | $181k 8,000 shares | -5% | |
| 28Weak | Tyra Biosciences, Inc. | Robert J More director | $5.0M 246,871 shares | -6% | |
| 43Moderate | Tyra Biosciences, Inc. | Daniel Bensen Chief Operating Officer | $2.0M 125,589 shares | -42% | |
| 43Moderate | Tyra Biosciences, Inc. | Daniel Bensen Chief Operating Officer | $2.1M 131,411 shares | -31% | |
| 35Weak | TYRAsell Tyra Biosciences, Inc. | Gilla Kaplan director | $94k 9,578 shares | -25% | |
| 53Moderate | TYRAsell Tyra Biosciences, Inc. | Gilla Kaplan director | $535k 51,814 shares | -58% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.